{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:35:55Z","timestamp":1795232155477,"version":"4.10.3"},"reference-count":13,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Drug Info"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Objective.\u2002<\/jats:bold> This study was conducted to characterize the pharmacokinetics, including extent of accumulation, and safety and tolerability of fentanyl following multiple doses of fentanyl buccal tablet (FBT) in healthy Japanese volunteers.<\/jats:p><jats:p><jats:bold>Methods.\u2002<\/jats:bold> Healthy Japanese adults received 10 successive doses of open\u2010label FBT 400\u2003\u00b5g at 6\u2010hour intervals. Naltrexone was given to minimize the opioid effects of fentanyl. FBT was placed above a molar tooth between the gum and cheek. Peak serum fentanyl concentration (C<jats:sub>max<\/jats:sub>), time to C<jats:sub>max<\/jats:sub> (t<jats:sub>max<\/jats:sub>), and area under the serum fentanyl concentration\u2010time curve from 0 to 6 hours (AUC<jats:sub>0\u20136<\/jats:sub>) were summarized using descriptive statistics. Accumulation ratio was calculated as C<jats:sub>max<\/jats:sub> for dose 10\/C<jats:sub>max<\/jats:sub> for dose 1, and was calculated similarly for AUC<jats:sub>0\u20136<\/jats:sub>.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> Fourteen volunteers (mean age 33 years) were enrolled, and 13 completed the study. After doses 1 and 10, respectively, mean (SD) C<jats:sub>max<\/jats:sub> was 1.70 (0.49) ng\/mL and 1.97 (0.42) ng\/mL, AUC<jats:sub>0\u20136<\/jats:sub> was 4.46 (1.14) ng\u00b7h\/mL and 6.81 (0.90) ng\u00b7h\/mL, and median (range) t<jats:sub>max<\/jats:sub> was 50 (30\u2013110) minutes and 30 (15\u2013120) minutes. Following 10 successive doses, systemic exposure (AUC<jats:sub>0\u20136<\/jats:sub>) was 55% higher than after dose 1, and C<jats:sub>max<\/jats:sub> was 23% higher. Steady state was achieved within 3 days of dosing at 6\u2010hour intervals, i.e., prior to dose 10. The most frequent adverse events (AEs) were somnolence (N\u2003=\u20039), decreased oxygen saturation (N\u2003=\u20034), headache (N\u2003=\u20033), application\u2010site pain (N\u2003=\u20038), application\u2010site erythema (N\u2003=\u20036), and application\u2010site reaction (N\u2003=\u20035). All AEs were mild or moderate.<\/jats:p><jats:p><jats:bold>Conclusions.\u2002<\/jats:bold> Following administration of FBT at 6\u2010hour intervals to healthy Japanese volunteers, at steady state, fentanyl exposure was higher by 55% (AUC<jats:sub>0\u20136<\/jats:sub>) and 23% (C<jats:sub>max<\/jats:sub>) than after a single dose of FBT. Adverse events were mild or moderate.<\/jats:p>","DOI":"10.1111\/j.1753-5174.2008.00008.x","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T14:05:30Z","timestamp":1213711530000},"page":"50-55","source":"Crossref","is-referenced-by-count":4,"title":["Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400\u2003\u00b5g in Healthy Japanese Volunteers"],"prefix":"10.1111","volume":"1","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tempero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Simonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ajp.0000210932.27945.4a"},{"key":"e_1_2_6_3_2","volume-title":"Fentora [prescribing information","year":"2007"},{"key":"e_1_2_6_4_2","first-page":"327","article-title":"Fentanyl buccal tablet for relief of breakthrough pain in opioid\u2010tolerant patients with cancer\u2010related chronic pain: A double\u2010blind, randomized, placebo\u2010controlled study","volume":"5","author":"Slatkin NE","year":"2007","journal-title":"J Support Oncol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00137696-200604010-00001"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.016"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645080-00006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544120-00006"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.015"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006297749"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199601000-00031"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004271969"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.13.2011"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006294129"}],"container-title":["Archives of Drug Information"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1753-5174.2008.00008.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1753-5174.2008.00008.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:00:29Z","timestamp":1697072429000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1753-5174.2008.00008.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1753-5174.2008.00008.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1753-5174.2008.00008.x","archive":["Portico"],"relation":{},"ISSN":["1753-5174","1753-5174"],"issn-type":[{"value":"1753-5174","type":"print"},{"value":"1753-5174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}